CardioPolymers Continues Development on Heart Failure Device
CardioPolymers (formerly Symphony Medical) of Laguna Hills, Calif., is developing a medical device to reverse CHF in patients who an enlarged left ventricle as a result of mitral valve regurgitation, ischemia, dilated cardiomyopathy and/or other disorders.